B. Riley analyst Jeff Van Sinderen downgraded Iteris to Neutral from Buy with a price target of $7.20, down from $8, after the company entered a merger agreement to be acquired by Almaviva for $7.20 per share in an all-cash transaction. The firm anticipates the deal will be completed per the company’s expectations.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ITI: